Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
AUTOR(ES)
Bax, D E
RESUMO
The place of sulphasalazine in the management of rheumatoid arthritis over prolonged periods of time has been compared and contrasted with that of sodium aurothiomalate. One hundred and forty-three patients (59 on sulphasalazine, 84 on sodium aurothiomalate) have been treated for periods of up to 42 months. Sulphasalazine is highly effective for some patients, though probably less frequently than sodium aurothiomalate. However, its safety profile is far superior, and very long-term treatment with sulphasalazine is a safe option for treatment of rheumatoid arthritis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1001604Documentos Relacionados
- Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.
- Changes in immune function in patients with rheumatoid arthritis following treatment with sodium aurothiomalate.
- Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.
- Leucopenia during sulphasalazine treatment for rheumatoid arthritis.
- Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis.